Cite

HARVARD Citation

    Moertel, C. et al. (2022). CD200AR-L: mechanism of action and preclinical and clinical insights for treating high-grade brain tumors. Expert opinion on investigational drugs. pp. 875-879. [Online]. 
  
Back to record